nodes	percent_of_prediction	percent_of_DWPC	metapath
Pasireotide—Gamma-glutamyltransferase increased—Roflumilast—chronic obstructive pulmonary disease	0.0181	0.0298	CcSEcCtD
Pasireotide—Adrenal insufficiency—Prednisone—chronic obstructive pulmonary disease	0.0142	0.0233	CcSEcCtD
Pasireotide—SSTR3—Peptide GPCRs—CXCR2—chronic obstructive pulmonary disease	0.0127	0.0333	CbGpPWpGaD
Pasireotide—SSTR1—Peptide GPCRs—CXCR2—chronic obstructive pulmonary disease	0.0122	0.0319	CbGpPWpGaD
Pasireotide—Electrocardiogram QT prolonged—Formoterol—chronic obstructive pulmonary disease	0.0118	0.0194	CcSEcCtD
Pasireotide—Electrocardiogram QT prolonged—Arformoterol—chronic obstructive pulmonary disease	0.0118	0.0194	CcSEcCtD
Pasireotide—SSTR5—Peptide GPCRs—CXCR2—chronic obstructive pulmonary disease	0.0108	0.0283	CbGpPWpGaD
Pasireotide—Octreotide—MPO—chronic obstructive pulmonary disease	0.0106	1	CrCbGaD
Pasireotide—SSTR2—Peptide GPCRs—CXCR2—chronic obstructive pulmonary disease	0.00997	0.0261	CbGpPWpGaD
Pasireotide—Hypercholesterolaemia—Tiotropium—chronic obstructive pulmonary disease	0.00989	0.0163	CcSEcCtD
Pasireotide—Influenza—Roflumilast—chronic obstructive pulmonary disease	0.00933	0.0154	CcSEcCtD
Pasireotide—SSTR2—GPCRs, Other—CXCR2—chronic obstructive pulmonary disease	0.00845	0.0221	CbGpPWpGaD
Pasireotide—Pain in extremity—Tiotropium—chronic obstructive pulmonary disease	0.00679	0.0112	CcSEcCtD
Pasireotide—Abdominal pain upper—Aminophylline—chronic obstructive pulmonary disease	0.00658	0.0108	CcSEcCtD
Pasireotide—Hypokalaemia—Aminophylline—chronic obstructive pulmonary disease	0.00655	0.0108	CcSEcCtD
Pasireotide—Back pain—Roflumilast—chronic obstructive pulmonary disease	0.00629	0.0104	CcSEcCtD
Pasireotide—Dry skin—Tiotropium—chronic obstructive pulmonary disease	0.00622	0.0102	CcSEcCtD
Pasireotide—SSTR3—Peptide ligand-binding receptors—CXCR2—chronic obstructive pulmonary disease	0.00598	0.0156	CbGpPWpGaD
Pasireotide—Diabetes mellitus—Salbutamol—chronic obstructive pulmonary disease	0.00595	0.00979	CcSEcCtD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.00594	0.0156	CbGpPWpGaD
Pasireotide—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.00584	0.00961	CcSEcCtD
Pasireotide—SSTR1—Peptide ligand-binding receptors—CXCR2—chronic obstructive pulmonary disease	0.00573	0.015	CbGpPWpGaD
Pasireotide—Hypoglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.00561	0.00924	CcSEcCtD
Pasireotide—Hypoglycaemia—Formoterol—chronic obstructive pulmonary disease	0.00561	0.00924	CcSEcCtD
Pasireotide—Hyperglycaemia—Aminophylline—chronic obstructive pulmonary disease	0.00561	0.00924	CcSEcCtD
Pasireotide—Myalgia—Roflumilast—chronic obstructive pulmonary disease	0.00553	0.00911	CcSEcCtD
Pasireotide—Anxiety—Roflumilast—chronic obstructive pulmonary disease	0.00552	0.00908	CcSEcCtD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.00536	0.014	CbGpPWpGaD
Pasireotide—Hypoglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.0053	0.00873	CcSEcCtD
Pasireotide—SSTR2—GPCRs, Other—ADRB2—chronic obstructive pulmonary disease	0.0053	0.0139	CbGpPWpGaD
Pasireotide—Hyperglycaemia—Tiotropium—chronic obstructive pulmonary disease	0.00529	0.00871	CcSEcCtD
Pasireotide—SSTR5—Peptide ligand-binding receptors—CXCR2—chronic obstructive pulmonary disease	0.00508	0.0133	CbGpPWpGaD
Pasireotide—SSTR3—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.00504	0.0132	CbGpPWpGaD
Pasireotide—Dry skin—Arformoterol—chronic obstructive pulmonary disease	0.00502	0.00827	CcSEcCtD
Pasireotide—Dry skin—Formoterol—chronic obstructive pulmonary disease	0.00502	0.00827	CcSEcCtD
Pasireotide—Hypokalaemia—Formoterol—chronic obstructive pulmonary disease	0.00499	0.00821	CcSEcCtD
Pasireotide—Hypokalaemia—Arformoterol—chronic obstructive pulmonary disease	0.00499	0.00821	CcSEcCtD
Pasireotide—Nasopharyngitis—Formoterol—chronic obstructive pulmonary disease	0.0049	0.00806	CcSEcCtD
Pasireotide—Nasopharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.0049	0.00806	CcSEcCtD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.00486	0.0127	CbGpPWpGaD
Pasireotide—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00483	0.00796	CcSEcCtD
Pasireotide—SSTR1—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.00483	0.0127	CbGpPWpGaD
Pasireotide—Aspartate aminotransferase increased—Montelukast—chronic obstructive pulmonary disease	0.00483	0.00795	CcSEcCtD
Pasireotide—Nasopharyngitis—Montelukast—chronic obstructive pulmonary disease	0.0048	0.0079	CcSEcCtD
Pasireotide—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.0048	0.0079	CcSEcCtD
Pasireotide—Influenza—Formoterol—chronic obstructive pulmonary disease	0.00474	0.00779	CcSEcCtD
Pasireotide—Influenza—Arformoterol—chronic obstructive pulmonary disease	0.00474	0.00779	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Montelukast—chronic obstructive pulmonary disease	0.00473	0.00779	CcSEcCtD
Pasireotide—Abdominal pain upper—Salbutamol—chronic obstructive pulmonary disease	0.00473	0.00778	CcSEcCtD
Pasireotide—Hypokalaemia—Salbutamol—chronic obstructive pulmonary disease	0.00471	0.00775	CcSEcCtD
Pasireotide—SSTR2—Peptide ligand-binding receptors—CXCR2—chronic obstructive pulmonary disease	0.00469	0.0123	CbGpPWpGaD
Pasireotide—SSTR3—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.00468	0.0123	CbGpPWpGaD
Pasireotide—Influenza—Montelukast—chronic obstructive pulmonary disease	0.00464	0.00763	CcSEcCtD
Pasireotide—Oedema peripheral—Tiotropium—chronic obstructive pulmonary disease	0.00463	0.00762	CcSEcCtD
Pasireotide—Nasopharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.00463	0.00762	CcSEcCtD
Pasireotide—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00461	0.00759	CcSEcCtD
Pasireotide—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00457	0.00753	CcSEcCtD
Pasireotide—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00454	0.00747	CcSEcCtD
Pasireotide—Abdominal distension—Salbutamol—chronic obstructive pulmonary disease	0.0045	0.00741	CcSEcCtD
Pasireotide—SSTR1—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.00449	0.0117	CbGpPWpGaD
Pasireotide—Influenza—Salbutamol—chronic obstructive pulmonary disease	0.00447	0.00736	CcSEcCtD
Pasireotide—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.0044	0.00724	CcSEcCtD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.00439	0.0115	CbGpPWpGaD
Pasireotide—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00434	0.00714	CcSEcCtD
Pasireotide—SSTR5—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.00429	0.0112	CbGpPWpGaD
Pasireotide—Hyperglycaemia—Formoterol—chronic obstructive pulmonary disease	0.00427	0.00703	CcSEcCtD
Pasireotide—Hyperglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.00427	0.00703	CcSEcCtD
Pasireotide—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00419	0.0069	CcSEcCtD
Pasireotide—SSTR2—GPCRs, Other—HTR2A—chronic obstructive pulmonary disease	0.00414	0.0109	CbGpPWpGaD
Pasireotide—Hyperglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.00403	0.00664	CcSEcCtD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.00401	0.0105	CbGpPWpGaD
Pasireotide—SSTR5—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.00398	0.0104	CbGpPWpGaD
Pasireotide—SSTR2—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.00396	0.0104	CbGpPWpGaD
Pasireotide—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.00395	0.00651	CcSEcCtD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.00384	0.0101	CbGpPWpGaD
Pasireotide—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00381	0.00627	CcSEcCtD
Pasireotide—Oedema peripheral—Formoterol—chronic obstructive pulmonary disease	0.00373	0.00615	CcSEcCtD
Pasireotide—Oedema peripheral—Arformoterol—chronic obstructive pulmonary disease	0.00373	0.00615	CcSEcCtD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.00372	0.00973	CbGpPWpGaD
Pasireotide—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.00368	0.00605	CcSEcCtD
Pasireotide—SSTR2—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.00367	0.00961	CbGpPWpGaD
Pasireotide—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00363	0.00598	CcSEcCtD
Pasireotide—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.00353	0.00581	CcSEcCtD
Pasireotide—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00351	0.00578	CcSEcCtD
Pasireotide—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.00348	0.00573	CcSEcCtD
Pasireotide—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.00348	0.00573	CcSEcCtD
Pasireotide—Diabetes mellitus—Prednisolone—chronic obstructive pulmonary disease	0.00341	0.00562	CcSEcCtD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.00341	0.00892	CbGpPWpGaD
Pasireotide—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00337	0.00555	CcSEcCtD
Pasireotide—SSTR3—Peptide ligand-binding receptors—EDN1—chronic obstructive pulmonary disease	0.00335	0.00877	CbGpPWpGaD
Pasireotide—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00332	0.00547	CcSEcCtD
Pasireotide—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00331	0.00544	CcSEcCtD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.00329	0.00861	CbGpPWpGaD
Pasireotide—SSTR1—Peptide ligand-binding receptors—EDN1—chronic obstructive pulmonary disease	0.00321	0.00841	CbGpPWpGaD
Pasireotide—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.0032	0.00527	CcSEcCtD
Pasireotide—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.00319	0.00525	CcSEcCtD
Pasireotide—Back pain—Formoterol—chronic obstructive pulmonary disease	0.00319	0.00525	CcSEcCtD
Pasireotide—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00315	0.00519	CcSEcCtD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.00315	0.00824	CbGpPWpGaD
Pasireotide—Hypercholesterolaemia—Prednisone—chronic obstructive pulmonary disease	0.00314	0.00517	CcSEcCtD
Pasireotide—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00308	0.00506	CcSEcCtD
Pasireotide—SSTR3—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.00305	0.00799	CbGpPWpGaD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.00304	0.00797	CbGpPWpGaD
Pasireotide—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00304	0.005	CcSEcCtD
Pasireotide—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00302	0.00497	CcSEcCtD
Pasireotide—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.00301	0.00496	CcSEcCtD
Pasireotide—SSTR3—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.00293	0.00769	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.00293	0.00766	CbGpPWpGaD
Pasireotide—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00289	0.00476	CcSEcCtD
Pasireotide—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00285	0.0047	CcSEcCtD
Pasireotide—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00285	0.00469	CcSEcCtD
Pasireotide—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00285	0.00469	CcSEcCtD
Pasireotide—SSTR5—Peptide ligand-binding receptors—EDN1—chronic obstructive pulmonary disease	0.00285	0.00746	CbGpPWpGaD
Pasireotide—SSTR1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.00281	0.00737	CbGpPWpGaD
Pasireotide—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00281	0.00462	CcSEcCtD
Pasireotide—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00281	0.00462	CcSEcCtD
Pasireotide—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00281	0.00462	CcSEcCtD
Pasireotide—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00281	0.00462	CcSEcCtD
Pasireotide—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.0028	0.00461	CcSEcCtD
Pasireotide—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.0028	0.00461	CcSEcCtD
Pasireotide—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.0028	0.00461	CcSEcCtD
Pasireotide—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.0028	0.0046	CcSEcCtD
Pasireotide—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00275	0.00453	CcSEcCtD
Pasireotide—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00275	0.00453	CcSEcCtD
Pasireotide—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00274	0.00451	CcSEcCtD
Pasireotide—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00273	0.00449	CcSEcCtD
Pasireotide—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.00272	0.00448	CcSEcCtD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.00269	0.00705	CbGpPWpGaD
Pasireotide—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00269	0.00443	CcSEcCtD
Pasireotide—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00265	0.00437	CcSEcCtD
Pasireotide—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00265	0.00437	CcSEcCtD
Pasireotide—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00264	0.00435	CcSEcCtD
Pasireotide—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00264	0.00434	CcSEcCtD
Pasireotide—SSTR2—Peptide ligand-binding receptors—EDN1—chronic obstructive pulmonary disease	0.00263	0.00688	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.0026	0.0068	CbGpPWpGaD
Pasireotide—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.00258	0.00425	CcSEcCtD
Pasireotide—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00252	0.00414	CcSEcCtD
Pasireotide—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00252	0.00414	CcSEcCtD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.00251	0.00658	CbGpPWpGaD
Pasireotide—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.0025	0.00412	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.0025	0.00655	CbGpPWpGaD
Pasireotide—SSTR5—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.0025	0.00653	CbGpPWpGaD
Pasireotide—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.00248	0.00408	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00245	0.00404	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00245	0.00404	CcSEcCtD
Pasireotide—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00244	0.00401	CcSEcCtD
Pasireotide—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00244	0.00401	CcSEcCtD
Pasireotide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00242	0.00399	CcSEcCtD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.00241	0.00631	CbGpPWpGaD
Pasireotide—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.0024	0.00396	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.0024	0.00628	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.0024	0.00627	CbGpPWpGaD
Pasireotide—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00239	0.00393	CcSEcCtD
Pasireotide—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00238	0.00391	CcSEcCtD
Pasireotide—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00236	0.00389	CcSEcCtD
Pasireotide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00234	0.00385	CcSEcCtD
Pasireotide—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00232	0.00382	CcSEcCtD
Pasireotide—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00232	0.00382	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00232	0.00381	CcSEcCtD
Pasireotide—Constipation—Formoterol—chronic obstructive pulmonary disease	0.0023	0.00379	CcSEcCtD
Pasireotide—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.0023	0.00379	CcSEcCtD
Pasireotide—SSTR2—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.0023	0.00603	CbGpPWpGaD
Pasireotide—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.0023	0.00379	CcSEcCtD
Pasireotide—SSTR3—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.00229	0.00601	CbGpPWpGaD
Pasireotide—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00227	0.00374	CcSEcCtD
Pasireotide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00225	0.0037	CcSEcCtD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.00225	0.00588	CbGpPWpGaD
Pasireotide—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00222	0.00365	CcSEcCtD
Pasireotide—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00221	0.00364	CcSEcCtD
Pasireotide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00221	0.00363	CcSEcCtD
Pasireotide—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.0022	0.00362	CcSEcCtD
Pasireotide—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.0022	0.00362	CcSEcCtD
Pasireotide—SSTR1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.0022	0.00576	CbGpPWpGaD
Pasireotide—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00219	0.00361	CcSEcCtD
Pasireotide—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00217	0.00358	CcSEcCtD
Pasireotide—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00216	0.00355	CcSEcCtD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.00215	0.00564	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.00214	0.0056	CbGpPWpGaD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.00214	0.0056	CbGpPWpGaD
Pasireotide—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00213	0.0035	CcSEcCtD
Pasireotide—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00213	0.0035	CcSEcCtD
Pasireotide—SSTR5—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.00213	0.00557	CbGpPWpGaD
Pasireotide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00212	0.00349	CcSEcCtD
Pasireotide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.0021	0.00346	CcSEcCtD
Pasireotide—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00209	0.00344	CcSEcCtD
Pasireotide—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00209	0.00343	CcSEcCtD
Pasireotide—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00208	0.00342	CcSEcCtD
Pasireotide—SSTR1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.00205	0.00537	CbGpPWpGaD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.00203	0.00532	CbGpPWpGaD
Pasireotide—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00201	0.00331	CcSEcCtD
Pasireotide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00198	0.00326	CcSEcCtD
Pasireotide—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.00198	0.00325	CcSEcCtD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.00197	0.00517	CbGpPWpGaD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.00197	0.00515	CbGpPWpGaD
Pasireotide—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.00196	0.00323	CcSEcCtD
Pasireotide—SSTR2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.00196	0.00514	CbGpPWpGaD
Pasireotide—SSTR5—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.00195	0.00511	CbGpPWpGaD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.00195	0.00511	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.00194	0.00509	CbGpPWpGaD
Pasireotide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00193	0.00318	CcSEcCtD
Pasireotide—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00193	0.00318	CcSEcCtD
Pasireotide—SSTR3—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.00191	0.00501	CbGpPWpGaD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.00191	0.005	CbGpPWpGaD
Pasireotide—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00191	0.00314	CcSEcCtD
Pasireotide—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00191	0.00314	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.0019	0.00313	CcSEcCtD
Pasireotide—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00189	0.00312	CcSEcCtD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.00188	0.00493	CbGpPWpGaD
Pasireotide—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.00188	0.00309	CcSEcCtD
Pasireotide—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00187	0.00307	CcSEcCtD
Pasireotide—SSTR1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.00186	0.00488	CbGpPWpGaD
Pasireotide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00184	0.00303	CcSEcCtD
Pasireotide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00184	0.00303	CcSEcCtD
Pasireotide—SSTR1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.00184	0.00481	CbGpPWpGaD
Pasireotide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00182	0.003	CcSEcCtD
Pasireotide—SSTR5—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.00182	0.00476	CbGpPWpGaD
Pasireotide—SSTR3—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.00181	0.00474	CbGpPWpGaD
Pasireotide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.0018	0.00297	CcSEcCtD
Pasireotide—SSTR2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.0018	0.00471	CbGpPWpGaD
Pasireotide—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.0018	0.00296	CcSEcCtD
Pasireotide—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00178	0.00293	CcSEcCtD
Pasireotide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00178	0.00293	CcSEcCtD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.00176	0.00462	CbGpPWpGaD
Pasireotide—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00174	0.00287	CcSEcCtD
Pasireotide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00174	0.00286	CcSEcCtD
Pasireotide—SSTR1—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.00174	0.00455	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.00172	0.00452	CbGpPWpGaD
Pasireotide—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00171	0.00282	CcSEcCtD
Pasireotide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00171	0.00282	CcSEcCtD
Pasireotide—SSTR3—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.00171	0.00448	CbGpPWpGaD
Pasireotide—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00169	0.00278	CcSEcCtD
Pasireotide—Headache—Formoterol—chronic obstructive pulmonary disease	0.00169	0.00278	CcSEcCtD
Pasireotide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00168	0.00277	CcSEcCtD
Pasireotide—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.00168	0.00277	CcSEcCtD
Pasireotide—SSTR2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.00168	0.0044	CbGpPWpGaD
Pasireotide—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00168	0.00276	CcSEcCtD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.00167	0.00438	CbGpPWpGaD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.00166	0.00436	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.00165	0.00433	CbGpPWpGaD
Pasireotide—Headache—Montelukast—chronic obstructive pulmonary disease	0.00165	0.00272	CcSEcCtD
Pasireotide—SSTR5—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.00165	0.00433	CbGpPWpGaD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.00165	0.00432	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.00164	0.0043	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.00163	0.00426	CbGpPWpGaD
Pasireotide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00162	0.00266	CcSEcCtD
Pasireotide—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.00161	0.00264	CcSEcCtD
Pasireotide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.0016	0.00263	CcSEcCtD
Pasireotide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.0016	0.00263	CcSEcCtD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.0016	0.00418	CbGpPWpGaD
Pasireotide—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00159	0.00262	CcSEcCtD
Pasireotide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00157	0.00258	CcSEcCtD
Pasireotide—SSTR3—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.00157	0.0041	CbGpPWpGaD
Pasireotide—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.00154	0.00254	CcSEcCtD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.00154	0.00404	CbGpPWpGaD
Pasireotide—SSTR5—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.00154	0.00403	CbGpPWpGaD
Pasireotide—SSTR3—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.00153	0.004	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.00152	0.00399	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.00151	0.00397	CbGpPWpGaD
Pasireotide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00151	0.00249	CcSEcCtD
Pasireotide—SSTR2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.0015	0.00393	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.0015	0.00393	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.0015	0.00392	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.00147	0.00384	CbGpPWpGaD
Pasireotide—SSTR1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.00146	0.00383	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.00145	0.00381	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.00145	0.0038	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.00144	0.00376	CbGpPWpGaD
Pasireotide—SSTR2—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.00142	0.00372	CbGpPWpGaD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.00141	0.0037	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.00135	0.00354	CbGpPWpGaD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.00135	0.00354	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.00134	0.00352	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.00133	0.00349	CbGpPWpGaD
Pasireotide—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.00132	0.00217	CcSEcCtD
Pasireotide—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.00132	0.00217	CcSEcCtD
Pasireotide—SSTR5—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.0013	0.0034	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.00129	0.00337	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.00127	0.00333	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.00123	0.00322	CbGpPWpGaD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.00121	0.00318	CbGpPWpGaD
Pasireotide—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.0012	0.00198	CcSEcCtD
Pasireotide—SSTR2—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.0012	0.00314	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.00119	0.00311	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.00117	0.00308	CbGpPWpGaD
Pasireotide—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.00117	0.00192	CcSEcCtD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.00116	0.00305	CbGpPWpGaD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.00116	0.00303	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.00115	0.00301	CbGpPWpGaD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.00114	0.00299	CbGpPWpGaD
Pasireotide—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.00112	0.00185	CcSEcCtD
Pasireotide—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.00111	0.00182	CcSEcCtD
Pasireotide—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.00111	0.00182	CcSEcCtD
Pasireotide—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.0011	0.00181	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.0011	0.00288	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.00108	0.00283	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.00104	0.00272	CbGpPWpGaD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.00103	0.0027	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000983	0.00257	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000976	0.00256	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000967	0.00253	CbGpPWpGaD
Pasireotide—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000966	0.00159	CcSEcCtD
Pasireotide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000964	0.00159	CcSEcCtD
Pasireotide—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000959	0.00158	CcSEcCtD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000953	0.0025	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000942	0.00247	CbGpPWpGaD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.000934	0.00245	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000927	0.00243	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000925	0.00242	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000925	0.00242	CbGpPWpGaD
Pasireotide—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000921	0.00152	CcSEcCtD
Pasireotide—SSTR5—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.00092	0.00241	CbGpPWpGaD
Pasireotide—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000914	0.0015	CcSEcCtD
Pasireotide—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000914	0.0015	CcSEcCtD
Pasireotide—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000906	0.00149	CcSEcCtD
Pasireotide—SSTR2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000901	0.00236	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000887	0.00232	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000887	0.00232	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000878	0.0023	CbGpPWpGaD
Pasireotide—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000867	0.00143	CcSEcCtD
Pasireotide—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000866	0.00143	CcSEcCtD
Pasireotide—SSTR2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000849	0.00222	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000846	0.00222	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000842	0.0022	CbGpPWpGaD
Pasireotide—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000838	0.00138	CcSEcCtD
Pasireotide—SSTR5—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000835	0.00219	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000822	0.00215	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000811	0.00212	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000787	0.00206	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000786	0.00206	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000771	0.00202	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000768	0.00201	CbGpPWpGaD
Pasireotide—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.00076	0.00125	CcSEcCtD
Pasireotide—SSTR2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000759	0.00199	CbGpPWpGaD
Pasireotide—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.00075	0.00123	CcSEcCtD
Pasireotide—SSTR5—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000747	0.00196	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000736	0.00193	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000726	0.0019	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000726	0.0019	CbGpPWpGaD
Pasireotide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000725	0.00119	CcSEcCtD
Pasireotide—SSTR5—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000719	0.00188	CbGpPWpGaD
Pasireotide—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000701	0.00115	CcSEcCtD
Pasireotide—SSTR2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000689	0.0018	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000677	0.00177	CbGpPWpGaD
Pasireotide—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000674	0.00111	CcSEcCtD
Pasireotide—Headache—Prednisone—chronic obstructive pulmonary disease	0.000664	0.00109	CcSEcCtD
Pasireotide—SSTR2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000664	0.00174	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000653	0.00171	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000649	0.0017	CbGpPWpGaD
Pasireotide—Nausea—Prednisone—chronic obstructive pulmonary disease	0.00063	0.00104	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000629	0.00165	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000603	0.00158	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000603	0.00158	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.00058	0.00152	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000575	0.00151	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000556	0.00146	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000535	0.0014	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000531	0.00139	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000523	0.00137	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000519	0.00136	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000501	0.00131	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000497	0.0013	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000494	0.00129	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000494	0.00129	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000475	0.00124	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000471	0.00123	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000455	0.00119	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000455	0.00119	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000454	0.00119	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000452	0.00118	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000444	0.00116	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000441	0.00115	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000435	0.00114	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000422	0.0011	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.00041	0.00107	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000407	0.00107	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000404	0.00106	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000404	0.00106	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000401	0.00105	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000386	0.00101	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000372	0.000975	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.00037	0.000969	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000359	0.000939	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000356	0.000932	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.000347	0.000908	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.000333	0.000871	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000331	0.000867	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000331	0.000867	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000317	0.000831	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000316	0.000828	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000303	0.000793	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.000295	0.000772	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000281	0.000737	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.00028	0.000734	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.000272	0.000713	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.000269	0.000704	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000269	0.000704	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	0.000267	0.000698	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.00026	0.00068	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	0.000256	0.000669	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	0.000254	0.000664	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000248	0.000649	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	0.000243	0.000637	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.000238	0.000624	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	0.000228	0.000596	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	0.000227	0.000594	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.00022	0.000576	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	0.000218	0.000572	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	0.000216	0.000565	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	0.000209	0.000548	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	0.000209	0.000547	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	0.000205	0.000537	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	0.0002	0.000525	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	0.000199	0.000521	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	0.000196	0.000514	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	0.000194	0.000507	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	0.000179	0.000468	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	0.000178	0.000465	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	0.000174	0.000456	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	0.000172	0.000451	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	0.000165	0.000432	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	0.000164	0.000429	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	0.000161	0.000421	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	0.000157	0.000412	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	0.000151	0.000395	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TP53—chronic obstructive pulmonary disease	0.000146	0.000383	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	0.000135	0.000354	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IL6—chronic obstructive pulmonary disease	0.000134	0.000351	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	0.000124	0.000324	CbGpPWpGaD
